181 related articles for article (PubMed ID: 16372246)
1. Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases.
Ruggeri RM; Barresi G; Sciacchitano S; Trimarchi F; Benvenga S; Trovato M
Histol Histopathol; 2006 Mar; 21(3):249-56. PubMed ID: 16372246
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
[TBL] [Abstract][Full Text] [Related]
3. Increased differentiation of Th22 cells in Hashimoto's thyroiditis.
Bai X; Sun J; Wang W; Shan Z; Zheng H; Li Y; Zhao Y; Gong M; Teng W
Endocr J; 2014; 61(12):1181-90. PubMed ID: 25242258
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of tissue IL-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases.
Zake T; Skuja S; Kalere I; Konrade I; Groma V
Medicine (Baltimore); 2018 Jun; 97(25):e11211. PubMed ID: 29924048
[TBL] [Abstract][Full Text] [Related]
5. The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders.
Marique L; Van Regemorter V; Gérard AC; Craps J; Senou M; Marbaix E; Rahier J; Daumerie C; Mourad M; Lengelé B; Colin IM; Many MC
J Clin Endocrinol Metab; 2014 May; 99(5):1722-32. PubMed ID: 24476075
[TBL] [Abstract][Full Text] [Related]
6. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis.
Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130
[TBL] [Abstract][Full Text] [Related]
7. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L
J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
[TBL] [Abstract][Full Text] [Related]
8. The expression and distribution of S-100 protein and CD 83 in thyroid tissues of autoimmune thyroid diseases.
Xu W; Chen S; Huang J; Zheng Z; Chen L; Zhang W
Cell Mol Immunol; 2004 Oct; 1(5):378-82. PubMed ID: 16285898
[TBL] [Abstract][Full Text] [Related]
9. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1β in Hashimoto's thyroiditis but not in Graves' disease.
Zake T; Skuja S; Kalere I; Konrade I; Groma V
Endocr J; 2019 May; 66(5):423-430. PubMed ID: 30814438
[TBL] [Abstract][Full Text] [Related]
10. CD30 expression and interleukin-4 and interferon-gamma production of intrathyroidal lymphocytes in Graves' disease.
Okumura M; Hidaka Y; Matsuzuka F; Takeoka K; Tada H; Kuma K; Amino N
Thyroid; 1999 Apr; 9(4):333-9. PubMed ID: 10319937
[TBL] [Abstract][Full Text] [Related]
11. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.
Kristensen B
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836805
[TBL] [Abstract][Full Text] [Related]
12. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease].
Zhang JA; Zhang J; Xu L; Mar H; Wu XY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):630-2. PubMed ID: 16948912
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
[TBL] [Abstract][Full Text] [Related]
15. Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population.
Mestiri S; Zaaber I; Inoubli O; Abid N; Omrani A; Nejehi H; Marmouch H
Int J Immunogenet; 2020 Jun; 47(3):294-308. PubMed ID: 31900992
[TBL] [Abstract][Full Text] [Related]
16. B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid Diseases.
Campi I; Tosi D; Rossi S; Vannucchi G; Covelli D; Colombo F; Trombetta E; Porretti L; Vicentini L; Cantoni G; Currò N; Beck-Peccoz P; Bulfamante G; Salvi M
Thyroid; 2015 Sep; 25(9):1043-9. PubMed ID: 26214745
[TBL] [Abstract][Full Text] [Related]
17. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders.
Vitales-Noyola M; Ramos-Levi AM; Martínez-Hernández R; Serrano-Somavilla A; Sampedro-Nuñez M; González-Amaro R; Marazuela M
Endocrine; 2017 Sep; 57(3):409-417. PubMed ID: 28669056
[TBL] [Abstract][Full Text] [Related]
19. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
20. The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases.
Jiskra J; Antosová M; Límanová Z; Telicka Z; Lacinová Z
Clin Exp Immunol; 2009 May; 156(2):211-6. PubMed ID: 19250272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
